UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mutational spectrum of the oral-facial-digital type I syndrome: a study on a large collection of patients

Human mutation, 2008-10, Vol.29 (10), p.1237-1246

2008

Volltextzugriff (PDF)

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility

Nature genetics, 2014-03, Vol.46 (3), p.234-244

2014

Volltextzugriff (PDF)

Multiethnic polygenic risk scores improve risk prediction in diverse populations

Genetic epidemiology, 2017-12, Vol.41 (8), p.811-823

2017

Volltextzugriff (PDF)

The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients

Diabetes care, 2013-09, Vol.36 (9), p.2615-2620

2013

Volltextzugriff (PDF)

Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers

Nature genetics, 2015-04, Vol.47 (4), p.381-386

2015

Volltextzugriff (PDF)

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history

Diabetes care, 2015-02, Vol.38 (2), p.271-276

2015

Volltextzugriff (PDF)

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes

Nature genetics, 2009-06, Vol.41 (6), p.703-707

2009

Volltextzugriff (PDF)

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

The New England journal of medicine, 2019-08, Vol.381 (7), p.603-613

2019

Volltextzugriff (PDF)

Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials

Diabetes care, 2017-11, Vol.40 (11), p.1494-1499

2017

Volltextzugriff (PDF)

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial―Type 1 Participants

Diabetes (New York, N.Y.), 2013-12, Vol.62 (12), p.4179-4183

2013

Volltextzugriff (PDF)

Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective

Diabetes (New York, N.Y.), 2022-04, Vol.71 (4), p.610-623

2022

Volltextzugriff (PDF)

Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico

Nature (London), 2014-02, Vol.506 (7486), p.97-101

2014

Volltextzugriff (PDF)

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

Science translational medicine, 2021-03, Vol.13 (583)

2021

Volltextzugriff (PDF)

Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association

Diabetes care, 2014-07, Vol.37 (7), p.2034-2054

2014

Volltextzugriff (PDF)

Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population

JAMA : the journal of the American Medical Association, 2014-06, Vol.311 (22), p.2305

2014

Volltextzugriff (PDF)

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes

Diabetes care, 2014-04, Vol.37 (4), p.979-984

2014

Volltextzugriff (PDF)

Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms

Endocrine reviews, 2018-10, Vol.39 (5), p.629-663

2018

Volltextzugriff (PDF)

N-Glycan Profile and Kidney Disease in Type 1 Diabetes

Diabetes care, 2018-01, Vol.41 (1), p.79-87

2018

Volltextzugriff (PDF)

CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study

Diabetes care, 2023-03, Vol.46 (3), p.526-534

2023

Volltextzugriff (PDF)

Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents

Diabetes care, 2020-03, Vol.43 (3), p.580-587

2020

Volltextzugriff (PDF)

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment

Diabetes care, 2014-04, Vol.37 (4), p.1069-1075

2014

Volltextzugriff (PDF)

Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies

Diabetologia, 2023-03, Vol.66 (3), p.415-424

2023

Volltextzugriff (PDF)

Severe Hypoglycemia and Cognitive Decline in Older People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study

Diabetes care, 2014-02, Vol.37 (2), p.507-515

2014

Volltextzugriff (PDF)

1 – 25 von 936

Suche als RSS-Feed

Aktive Filter

SpracheNiederländisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(722)
Mit Volltextzugriff
(703)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(514)
Life Sciences & Biomedicine
(486)
Humans
(442)
Male
(285)
Female
(284)
Endocrinology & Metabolism
(260)
Diabetes
(259)
Adult
(175)
Middle Aged
(169)
Biological And Medical Sciences
(158)
Adolescent
(151)
Medical Sciences
(147)
Type 1 Diabetes
(142)
Child
(127)
Risk Factors
(125)
Diabetes Mellitus
(124)
Diabetes. Impaired Glucose Tolerance
(121)
Endocrine Pancreas. Apud Cells
(121)
Endocrinopathies
(121)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(104)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Mutational spectrum of the oral-facial-digital type I syndrome: a study on a large collection of patients

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility

Multiethnic polygenic risk scores improve risk prediction in diverse populations

The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients

Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes

Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial―Type 1 Participants

Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective

Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association

Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes

Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms

N-Glycan Profile and Kidney Disease in Type 1 Diabetes

CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study

Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment

Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies

Severe Hypoglycemia and Cognitive Decline in Older People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study

Aktive Filter

Suchergebnisse filtern